Abstract
‘Bystander’ killing of adjacent wild-type tumor cells was seen when tumors transduced with the herpes thymidine kinase gene were treated with the antiviral agent ganciclovir (GCV). Some tumors were ‘bystander-sensitive’ while others were ‘bystander-resistant’. Mixtures of different ‘sensitive’ tumor lines showed cross-transfer of bystander killing, while in mixtures of ‘resistant’ with ‘sensitive’ tumors, the resistant phenotype was predominant. Using 3H-GCV with ‘sensitive’ mixtures, phosphorylated 3H-GCV was found in both herpes thymidine kinase transduced and unmodified cells, while ‘resistant’ cell combinations showed little or no transfer of phosphorylated GCV between cells. The capacity of intracellularly produced nucleotide toxin to spread from cell to cell within a tumor mass effectively amplifies the apparent efficiency of gene transfer in the tumor and makes feasible the use of this system for therapy of localized cancer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ishii-Morita, H., Agbaria, R., Mullen, C. et al. Mechanism of ‘bystander effect’ killing in the herpes simplex thymidine kinase gene therapy model of cancer treatment. Gene Ther 4, 244–251 (1997). https://doi.org/10.1038/sj.gt.3300379
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3300379
Keywords
This article is cited by
-
Demonstration of anti-tumour bystander killing with prodrug-preloaded suicide gene-engineered tumour cells: a potential improvement for cancer therapeutics
Cancer Cell International (2020)
-
The impact of γ-irradiation on the induction of bystander killing by genetically engineered ovarian tumor cells: implications for clinical use
Cancer Cell International (2017)
-
Generation of Gross Chromosomal Rearrangements by a Single Engineered DNA Double Strand Break
Scientific Reports (2017)
-
Genetic studies in mice directly link oocytes produced during adulthood to ovarian function and natural fertility
Scientific Reports (2017)
-
Human amniotic fluid-derived stem cells expressing cytosine deaminase and thymidine kinase inhibits the growth of breast cancer cells in cellular and xenograft mouse models
Cancer Gene Therapy (2012)